Select a profile:

• Masimo
  • Anesthesia Business Consultants
  • B. Braun Medical Inc.
  • Dräger
  • Edwards Lifesciences
  • Grifols
  • MAQUET Medical Systems USA
  • McMahon Publishing
  • Mindray
  • Pacira Pharmaceuticals, Inc.
  • Par Sterile Products, LLC
  • Spacelabs Healthcare
  • TeamHealth Anesthesia
  • Teleflex
  •  

Masimo

Taking noninvasive monitoring to new sites and applications

For 25 years, Masimo has focused on a singular mission—helping clinicians improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications.

Continuing to SET the Benchmark for Oxygenation Monitoring During Challenging Conditions

Masimo SET^® (Signal Extraction Technology^®) is the proven leader in pulse oximetry, demonstrated by both clinical research and the real-world success of customers and OEM partners. More than 100 independent and objective studies have shown that Masimo SET^® outperforms all other pulse oximetry technologies, providing clinicians with unmatched sensitivity and specificity to make critical patient care decisions—even under the challenging conditions of motion and low perfusion.¹ Most importantly, only Masimo SET^® pulse oximetry has been shown to improve patient outcomes by helping clinicians reduce retinopathy of prematurity,² screen newborns for critical congenital heart disease,^3,4 reduce ventilator weaning time⁵ and save lives, while reducing rapid response activations and ICU transfers on medical-surgical floors.⁶

rainbow^® Technology Helps Clinicians Protect Patients From Hidden Dangers Throughout the Hospital

rainbow^® technology comprises a suite of continuous, noninvasive measurements designed to help clinicians with some of the most common, costly and critical decisions made in health care today. The rainbow^® SET^® suite includes:

• Total Hemoglobin (SpHb^®)
• Methemoglobin (SpMet^®)
• Carboxyhemoglobin (SpCO^®)
• Oxygen Content (SpOC™)
• Acoustic Respiration Rate (RRa^®)
• All Masimo SET^® measurements

Helping Clinicians Optimize Blood Management

Red blood cell (RBC) transfusion is one of the most frequent procedures performed in U.S. hospitals, with one in 10 inpatients receiving one or more blood units.⁷ However, a growing body of clinical evidence suggests that overuse of RBC transfusion increases both patient risk and the cost of care.^8,9,10,11 Masimo’s continuous, noninvasive total hemoglobin monitoring (SpHb) has been shown to help clinicians reduce RBC transfusions in low blood loss surgery¹² and high blood loss surgery.¹³ In addition, by measuring hemoglobin continuously, SpHb may help clinicians identify real-time drops in hemoglobin that may indicate bleeding. Although SpHb monitoring is not intended to replace blood draws, continuous monitoring of hemoglobin levels could allow earlier interventions that may prevent disability or death.

Protecting More Patients by Monitoring Every Breath

Radical-7® features rainbow® SET® measurements, intuitive touchscreen display, standard wireless radio and full-screen trending.

The Anesthesia Patient Safety Foundation (APSF) and the Joint Commission recommend continuous oxygenation and ventilation monitoring in all patients receiving opioid-based pain medications.¹⁴ However, current methods for respiration rate monitoring are limited by accuracy and patient tolerance. Although we offer best-in-class capnography solutions, we believe rainbow Acoustic Monitoring™ with Acoustic Respiration Rate (RRa) can help clinicians better monitor patient breathing in postsurgical and conscious sedation situations due to its demonstrated ability to detect respiratory pause.¹⁵

Helping Improve Outcomes on Medical-Surgical Units with Masimo Patient SafetyNet^™a

In August 2012, the Joint Commission Sentinel Event Alert on the safe use of opioids in hospitals recommended implementation of better dosing along with continuous oxygenation and ventilation monitoring (instead of spot-checks) in postsurgical patients.¹⁶ Our Patient SafetyNet system combines Masimo SET^® pulse oximetry, breakthrough rainbow^® measurements and remote patient monitoring with wireless clinician alerts. After implementing Masimo SET^® and Patient SafetyNet on a postsurgical floor where only intermittent spot-checking was used before, Dartmouth-Hitchcock Medical Center reduced rapid response activations by 65% and ICU transfers by 48%,6 and saved $1.48 million annually. In addition, no patients suffered irreversible, severe brain damage or died as a result of respiratory depression from opioids over a five-year period.17

a The use of the trademarks PATIENT SAFETYNET and PSN is under license from University Health System Consortium.

References

1. Shah N, Ragaswamy HB, Govindugari K, Estanol L. J Clin Anesth. 2012:24:385-391.
2. Castillo A, et al. Acta Paediatr. 2011;100:188-192.
3. de-Wahl Granelli AD, et al. BMJ. 2009;338.
4. Ewer A, et al. Health Technol Assess. 2012;16:1-184.
5. Durbin CG Jr, et al. Crit Care Med. 2002;30:1735-1740.
6. Taenzer AH, et al. Anesthesiology. 2010;112:282-287.
7. AHRQ. Inpatient Sample. 1997-2007.
8. Marik PE, et al. Crit Care Med. 2008;36:2667-2674.
9. Carson JL, et al. Cochrane Database Syst Rev. 2012;4:CD002042.
10. Shander A, et al. Transfusion. 2010;50:753-765.
11. Murphy GJ, et al. Circulation. 2007;116:2544-2552.
12. Ehrenfeld JM, et al. American Society of Anesthesiologists Annual Meeting. 2010:LB05 (abstract).
13. Awada WFN, Maher F. Proceeding of the Society for Technology in Anesthesia Annual Meeting. 2013:51.
14. Stoelting RK, et al. APSF Newsletter. 2011. www.apsf.org.

15. Ramsay M, et al. Anesth Analg. doi: 10.1213/ ANE.0b013e318290c798.
16. The Joint Commission. Sentinel Event Alert! 2012:49.
17. Taenzer AH, et al. APSF Newsletter. 2012;27:1.

This corporate profile was reviewed and approved by Masimo.

Close